Trends in the treatment of proximal humerus fractures over an 11 year period in New York state

Authors

Kingery MT

Co-Authors:

Romeo, Papalia, Anil U, Lin C, Virk MS

Published

April 14, 2023

Methods

Data collection

The SPARCS database was queried for all patients presenting with a proximal humerus fracture in New York state from January 2010 to December 2020 based on ICD code of the principal diagnosis. Pathologic fractures and pediatric physeal fractures were excluded from this analysis. After the relevant patient cohort was identified, all subsequent encounters for each patient were evaluated to determine whether patients were treated operatively or nonoperatively. For patients treated operatively, the specific procedure was determined by ICD procedure code and/or CPT code. Any subsequent ED visits, readmissions, or reoperations were recorded. A pre-specified list of relevant postoperative complications was compiled to identify any subsequent complications based on ICD code. Specific complication diagnoses were categorized into groups which included nonunion, malunion, infection, wound complications, osteolysis, instability, mechanical complications, periprosthetic fractures, shoulder stiffness, neuropathy, and persistent shoulder pain.

Statistical analysis

All statistical analysis was performed using R (R Foundation for Statistical Computing; Vienna, Austria). Simple comparisons between groups were performed with standard statistical tests (i.e., t-tests, chi-squared tests, Fisher’s exact test as appropriate). A multivariable logistic regression model was used to evaluate the odds of undergoing reoperation following operative treatment of a proximal humerus fracture with either rTSA or ORIF when controlling for underlying confounding variables.

Code
n_overall <- format(nrow(df), big.mark = ',')
age_overall <- paste(round(mean(df$age), 1), '+/-', round(sd(df$age), 1))

# summarize percentage of op vs nonop patients by year
minmax_perc_op <- df %>% 
  group_by(disch_yr, eventual_treatment) %>% 
  count() %>% 
  ungroup() %>% 
  group_by(disch_yr) %>% 
  mutate(perc = 100*(n/sum(n))) %>% 
  ungroup %>%
  filter(eventual_treatment == 'operative') %>% 
  summarise(min_perc = round(min(perc), 1),
            min_perc_year = disch_yr[which.min(perc)],
            max_perc = round(max(perc), 1),
            max_perc_year = disch_yr[which.max(perc)])


n_operative <- df %>% filter(eventual_treatment == 'operative') %>% nrow()
n_orif <- df %>% filter(surgery == 'orif') %>% nrow()
n_rtsa <- df %>% filter(surgery == 'rTSA') %>% nrow()
n_hemi <- df %>% filter(surgery == 'hemi') %>% nrow() 
# n_atsa <- df %>% filter(surgery == 'aTSA') %>% nrow()

# summarize percentage of hemis over time in >65 cohort
minmax_perc_hemi <- df %>% 
  filter(age_bins == '65+',
         eventual_treatment == 'operative') %>% 
  group_by(disch_yr, surgery) %>% 
  count() %>% 
  ungroup() %>% 
  group_by(disch_yr) %>% 
  mutate(perc = 100*(n/sum(n))) %>% 
  ungroup %>%
  filter(surgery == 'hemi') %>% 
  summarise(mean_1 = round(mean(perc[1:3]), 1),
            mean_3 = round(mean(perc[9:11]), 1))

Results

Demographics

A total of 92,308 patients sustained a proximal humerus fracture during the study period and were included in this analysis. The mean age of patients presenting with proximal humerus fractures during the study period was 67.8 +/- 16.8 and 72.5% were female. 39.1% of fractures were specified as two-part fractures. However, 59% of cases were not associated with an ICD code for a specific fracture pattern. Therefore, the distribution of two-, three-, and four-part fractures is unlikely to be accurate.

Overall, 16.8% of patients with proximal humerus fractures were treated operatively. There was a small general decrease in the percentage of patients treated operatively over the course of the study period (p < 0.001). The lowest percentage of operatively treated patients was 14% in 2017, while the highest percentage was 20.2% in 2010 (Figure 1). On average, patients treated operatively were younger (64.9 +/- 15.1 years versus 68.4 +/- 17.1 years, p < 0.001), more likely to be white (80.2% versus 74.7%, p < 0.001), and more likely to have private insurance (41.4% versus 32.0%, p < 0.001). The mean follow up duration for operative cases was 3.0 +/- 2.9 years (Table 1).

Table 1: Patient demographics for all patients treated for a proximal humerus fracture in New York from 2010 to 2020.
Characteristic Overall, N = 92,3081 Treatment p-value2
Nonoperative, N = 76,7851 Operative, N = 15,5231
Age (years) 67.8 +/- 16.8 68.4 +/- 17.1 64.9 +/- 15.1 <0.001
Sex 0.003
    Female 66,885 (72.5%) 55,787 (72.7%) 11,098 (71.5%)
    Male 25,422 (27.5%) 20,997 (27.3%) 4,425 (28.5%)
Fracture type <0.001
    Two part fracture 36,073 (39.1%) 30,350 (39.5%) 5,723 (36.9%)
    Three part fracture 980 (1.1%) 498 (0.6%) 482 (3.1%)
    Four part fracture 775 (0.8%) 174 (0.2%) 601 (3.9%)
    Unspecified fracture 54,480 (59.0%) 45,763 (59.6%) 8,717 (56.2%)
Race <0.001
    White 69,650 (75.6%) 57,193 (74.7%) 12,457 (80.2%)
    Black 5,133 (5.6%) 4,561 (6.0%) 572 (3.7%)
    Hispanic 7,443 (8.1%) 6,512 (8.5%) 931 (6.0%)
    Asian 2,059 (2.2%) 1,757 (2.3%) 302 (1.9%)
    Native American 271 (0.3%) 226 (0.3%) 45 (0.3%)
    Other or Unknown 7,532 (8.2%) 6,316 (8.2%) 1,216 (7.8%)
Elixhauser score 1.6 +/- 4.3 1.6 +/- 4.2 1.9 +/- 5.0 <0.001
Insurance <0.001
    Private 30,981 (33.6%) 24,556 (32.0%) 6,425 (41.4%)
    Medicare 49,178 (53.3%) 41,803 (54.4%) 7,375 (47.5%)
    Medicaid 5,314 (5.8%) 4,512 (5.9%) 802 (5.2%)
    Worker's Compensation 2,457 (2.7%) 1,908 (2.5%) 549 (3.5%)
    Other 4,377 (4.7%) 4,005 (5.2%) 372 (2.4%)
Follow-up duration (years) 2.5 +/- 2.7 2.4 +/- 2.7 3.0 +/- 2.9 <0.001
1 Mean +/- SD; n (%)
2 Welch Two Sample t-test; Pearson's Chi-squared test

Figure 1: Trends in the nonoperative versus operative treatment of proximal humerus fractures.

Operative treatment of proximal humerus fractures

Of the 15,523 patients treated operatively, 72.2% were treated with ORIF, 18.3% were treated with rTSA, and 9.5% were treated with hemiarthroplasty (Table 2). Over the course of the 10 year study period, the percentage of proximal humerus fractures treated with rTSA increased significantly, particularly in patients over 65 years of age. There was a corresponding decrease in the proportion of fractures treated with ORIF in patients over 65. In 2019, the number of proximal humerus fractures treated with rTSA was greater than the number of proximal humerus fractures treated with ORIF (Figure 2). Concurrently, as the proportion of rTSAs increased over time, the number of hemiarthroplasties performed for proximal humerus fractures decreased rapidly. In the over 65 age cohort, 27.1% of patients with operatively treated proximal humerus fractures underwent hemiarthroplasty during the first three years of the study period. This decreased to 0.6% during the final three years of the study period.

Table 2: Patient characteristics for patients with proximal humerus fractures treated operatively.
Characteristic Surgical Procedure p-value2
Hemiarthroplasty, N = 1,4741 rTSA, N = 2,8411 ORIF, N = 11,2081
Fracture type <0.001
    Two part fracture 377 (25.6%) 532 (18.7%) 4,814 (43.0%)
    Three part fracture 2 (0.1%) 121 (4.3%) 359 (3.2%)
    Four part fracture 7 (0.5%) 435 (15.3%) 159 (1.4%)
    Unspecified fracture 1,088 (73.8%) 1,753 (61.7%) 5,876 (52.4%)
Malunion or nonunion as indication <0.001
    None 1,422 (96.5%) 2,565 (90.3%) 10,942 (97.6%)
    Malunion 21 (1.4%) 107 (3.8%) 53 (0.5%)
    Nonunion 31 (2.1%) 169 (5.9%) 213 (1.9%)
Age (years) 71.1 +/- 11.6 73.8 +/- 9.1 61.9 +/- 15.6 <0.001
Sex <0.001
    Female 1,127 (76.5%) 2,321 (81.7%) 7,650 (68.3%)
    Male 347 (23.5%) 520 (18.3%) 3,558 (31.7%)
Race <0.001
    White 1,215 (82.4%) 2,422 (85.3%) 8,820 (78.7%)
    Black 43 (2.9%) 61 (2.1%) 468 (4.2%)
    Hispanic 94 (6.4%) 119 (4.2%) 718 (6.4%)
    Asian 26 (1.8%) 42 (1.5%) 234 (2.1%)
    Native American 3 (0.2%) 9 (0.3%) 33 (0.3%)
    Other or Unknown 93 (6.3%) 188 (6.6%) 935 (8.3%)
Elixhauser score 2.8 +/- 5.4 2.3 +/- 5.6 1.7 +/- 4.8 <0.001
Insurance <0.001
    Private 445 (30.2%) 654 (23.0%) 5,326 (47.5%)
    Medicare 899 (61.0%) 2,023 (71.2%) 4,453 (39.7%)
    Medicaid 49 (3.3%) 77 (2.7%) 676 (6.0%)
    Worker's Compensation 53 (3.6%) 62 (2.2%) 434 (3.9%)
    Other 28 (1.9%) 25 (0.9%) 319 (2.8%)
Follow-up duration (years) 4.6 +/- 3.2 2.1 +/- 2.2 3.0 +/- 3.0 <0.001
Length of stay (days) 5.1 +/- 4.9 3.5 +/- 3.4 4.4 +/- 4.8 <0.001
Accommodation charge ($) 15,454.2 +/- 20,752.4 13,417.5 +/- 18,118.7 13,317.0 +/- 24,557.5 0.005
Ancillary charge ($) 39,467.1 +/- 24,830.7 67,182.1 +/- 44,215.6 35,218.4 +/- 30,190.6 <0.001
Total charge ($) 53,398.4 +/- 39,140.0 80,442.6 +/- 51,867.1 42,225.5 +/- 42,904.2 <0.001
1 n (%); Mean +/- SD
2 Pearson's Chi-squared test; One-way ANOVA; Fisher's Exact Test for Count Data with simulated p-value (based on 2000 replicates)

Figure 3: Trends in the treatment of proximal humerus fractures by insurance type.

Operative outcomes

The rate of postoperative complications and reoperations was evaluated for patients with at least one year of postoperative follow up (Table 3).

When directly comparing the outcomes of ORIF and rTSA, there was no difference in rate of surgical complications (\(\chi^2\) = 0.245, p = 0.621) or reoperations (\(\chi^2\) = 0.112, p = 0.730) between groups. There was no difference between the ORIF and rTSA groups with respect to all-cause readmission within 3 months (\(\chi^2\) = 1.046, p = 0.307) or 1 year of surgery (\(\chi^2\) = 3.666, p = 0.056).

Based on a multivariable logistic regression model to control for age, general medical status as approximated by Elixhauser score, and the duration of follow-up, there was no overall difference in the odds of undergoing reoperation between patients who underwent rTSA and patients who underwent ORIF. However, there was a significant interaction effect between procedure and fracture pattern. Patients with four part fractures who underwent ORIF demonstrated a significantly greater odds of undergoing reoperation (Table 4).

Table 3: Outcomes following surgical treatment of proximal humerus fractures based on specific procedure. Includes only patients with at least 1 year of postoperative follow-up.
Characteristic Surgical Procedure p-value2
Hemiarthroplasty, N = 1,1661 rTSA, N = 1,6501 ORIF, N = 6,9411
Any surgical complication 183 (15.7%) 260 (15.8%) 1,131 (16.3%) 0.790
    Nonunion 10 (0.9%) 11 (0.7%) 138 (2.0%) <0.001
    Malunion 2 (0.2%) 5 (0.3%) 57 (0.8%) 0.006
    Neuropathy 0 (0.0%) 1 (0.1%) 1 (0.0%) 0.494
    Infection 55 (4.7%) 62 (3.8%) 223 (3.2%) 0.028
    Stiffness 28 (2.4%) 54 (3.3%) 326 (4.7%) <0.001
    Instability 63 (5.4%) 93 (5.6%) 261 (3.8%) <0.001
    Osteolysis 3 (0.3%) 1 (0.1%) 5 (0.1%) 0.154
    Periprosthetic fracture 11 (0.9%) 32 (1.9%) 32 (0.5%) <0.001
    Wound complication 11 (0.9%) 21 (1.3%) 101 (1.5%) 0.356
    Mechanical complication 36 (3.1%) 41 (2.5%) 103 (1.5%) <0.001
    Persistent shoulder pain 15 (1.3%) 20 (1.2%) 167 (2.4%) 0.001
Any medical complication 92 (7.9%) 145 (8.8%) 445 (6.4%) 0.001
Any reoperation 104 (8.9%) 117 (7.1%) 473 (6.8%) 0.035
    Revision arthroplasty 83 (7.1%) 99 (6.0%) 349 (5.0%) 0.008
    Debridement 25 (2.1%) 29 (1.8%) 106 (1.5%) 0.283
    Revision ORIF 1 (0.1%) 2 (0.1%) 36 (0.5%) 0.010
    Fixation of periprosthetic fracture 1 (0.1%) 2 (0.1%) 6 (0.1%) 0.866
Time to first revision (years) 1.6 +/- 2.1 1.4 +/- 1.6 1.0 +/- 1.3 <0.001
Readmission within 3 months 151 (13.0%) 214 (13.0%) 834 (12.0%) 0.435
Readmission within 12 months 266 (22.8%) 380 (23.0%) 1,447 (20.8%) 0.073
Mortality within 3 months 0 (0.0%) 2 (0.1%) 1 (0.0%) 0.115
Mortality within 12 months 1 (0.1%) 7 (0.4%) 10 (0.1%) 0.053
1 n (%); Mean +/- SD
2 Pearson's Chi-squared test; Fisher's exact test; One-way ANOVA
Code
# orif versus rtsa with 1 year follow up
df.orifvrtsa <- df %>% 
  filter(eventual_treatment == 'operative') %>% 
  filter(surgery == 'orif' | surgery == 'rTSA') %>% 
  filter(followup > 1)

# chisq.test(df.orifvrtsa$any_surgical_complication, df.orifvrtsa$surgery)
# chisq.test(df.orifvrtsa$eventual_revision, df.orifvrtsa$surgery)
# chisq.test(df.orifvrtsa$readmission_within_3months, df.orifvrtsa$surgery)
# chisq.test(df.orifvrtsa$readmission_within_12months, df.orifvrtsa$surgery)
# 
# m1 <- glm(readmission_within_12months ~ surgery + age,
#           data = df.orifvrtsa,
#           family = 'binomial')
# summary(m1)


df.ind <- df.orifvrtsa %>%
  filter(indication_fxtype != 'unspecifiedfx') %>% 
  mutate(indication_fxtype = recode_factor(indication_fxtype,
                                    '2partfx' = 'Two part fracture',
                                    '3partfx' = 'Three part fracture',
                                    '4partfx' = 'Four part fracture')) %>% 
  mutate(surgery = recode_factor(surgery,
                                 'rTSA' = 'rTSA',
                                 'orif' = 'ORIF'))

m2 <- glm(eventual_revision ~ surgery*indication_fxtype + age + elixhauser_score + followup,
          data = df.ind,
          family = 'binomial')
summary(m2)

Call:
glm(formula = eventual_revision ~ surgery * indication_fxtype + 
    age + elixhauser_score + followup, family = "binomial", data = df.ind)

Deviance Residuals: 
    Min       1Q   Median       3Q      Max  
-0.9276  -0.3774  -0.3321  -0.2899   2.7090  

Coefficients:
                                                  Estimate Std. Error z value
(Intercept)                                      -1.945958   0.433986  -4.484
surgeryORIF                                      -0.241307   0.259424  -0.930
indication_fxtypeThree part fracture             -0.982656   1.039578  -0.945
indication_fxtypeFour part fracture              -0.527977   0.480503  -1.099
age                                              -0.016310   0.004804  -3.395
elixhauser_score                                  0.041990   0.012717   3.302
followup                                          0.073933   0.028021   2.639
surgeryORIF:indication_fxtypeThree part fracture  0.595845   1.137003   0.524
surgeryORIF:indication_fxtypeFour part fracture   1.738803   0.598029   2.908
                                                 Pr(>|z|)    
(Intercept)                                      7.33e-06 ***
surgeryORIF                                      0.352286    
indication_fxtypeThree part fracture             0.344534    
indication_fxtypeFour part fracture              0.271855    
age                                              0.000686 ***
elixhauser_score                                 0.000961 ***
followup                                         0.008327 ** 
surgeryORIF:indication_fxtypeThree part fracture 0.600245    
surgeryORIF:indication_fxtypeFour part fracture  0.003643 ** 
---
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1

(Dispersion parameter for binomial family taken to be 1)

    Null deviance: 1717.1  on 3780  degrees of freedom
Residual deviance: 1678.9  on 3772  degrees of freedom
AIC: 1696.9

Number of Fisher Scoring iterations: 6
Code
rt1 <- m2 %>% 
  tbl_regression(exponentiate = TRUE,
                 label = list(
                   surgery ~ 'Procedure',
                   indication_fxtype ~ 'Fracture type',
                   age ~ 'Age (years)',
                   elixhauser_score ~ 'Elixhauser score',
                   followup ~ 'Follow-up duration (years)'
                   ),
                 pvalue_fun = function(x) style_pvalue(x, digits = 3)) %>% 
  bold_p(t = 0.05) %>%
  modify_caption("<div style='text-align: left; font-weight: bold'>
                 Odds of undergoing reoperation") %>%
  as_gt() %>%
  gt::tab_options(
    table.font.size = 'small',
    data_row.padding = gt::px(3)
  )
rt1
Table 4: Regression model results evaluating the odds of undergoing reoperation following operative treatment of proximal humerus fracture with ORIF or rTSA when controlling for underlying confounders of age, Elixhauser score, and duration of follow-up.
Characteristic OR1 95% CI1 p-value
Procedure
    rTSA
    ORIF 0.79 0.48, 1.34 0.352
Fracture type
    Two part fracture
    Three part fracture 0.37 0.02, 1.88 0.345
    Four part fracture 0.59 0.21, 1.43 0.272
Age (years) 0.98 0.97, 0.99 <0.001
Elixhauser score 1.04 1.02, 1.07 <0.001
Follow-up duration (years) 1.08 1.02, 1.14 0.008
Procedure * Fracture type
    ORIF * Three part fracture 1.81 0.26, 36.3 0.600
    ORIF * Four part fracture 5.69 1.79, 19.2 0.004
1 OR = Odds Ratio, CI = Confidence Interval
Code
# rt1 %>% gt::gtsave(filename = 'rt1.png',
#                   path = here('reports/'))